2021
DOI: 10.1101/2021.09.10.459853
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Probing neuropeptide volume transmission in vivo by a novel all-optical approach

Abstract: Neuropeptides are essential signaling molecules in the nervous system involved in modulating neural circuits and behavior. Although hypothesized to signal via volume transmission through G-protein coupled receptors (GPCR), remarkably little is known about their extrasynaptic diffusion. Here, we developed an all-optical approach to probe neuropeptide volume transmission in mouse neocortex. To control neuropeptide release, we engineered photosensitive nanovesicles with somatostatin-14 (SST) that is released with… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 58 publications
(91 reference statements)
0
8
0
Order By: Relevance
“…Although limited work has assessed changes in SST peptide release or expression in substance use disorders, SST represents a potential therapeutic target for a variety of neuropsychiatric illnesses (Brockway and Crowley, 2020). Future experiments should investigate changes in SST peptide release throughout development and following alcohol exposure using both optogenetic techniques (Dao et al, 2019), in vivo recording (Brockway et al, 2022, preprint), and novel biosensors (Wang et al, 2022, preprint; Xiong et al, 2021, preprint).…”
Section: Discussionmentioning
confidence: 99%
“…Although limited work has assessed changes in SST peptide release or expression in substance use disorders, SST represents a potential therapeutic target for a variety of neuropsychiatric illnesses (Brockway and Crowley, 2020). Future experiments should investigate changes in SST peptide release throughout development and following alcohol exposure using both optogenetic techniques (Dao et al, 2019), in vivo recording (Brockway et al, 2022, preprint), and novel biosensors (Wang et al, 2022, preprint; Xiong et al, 2021, preprint).…”
Section: Discussionmentioning
confidence: 99%
“…Peptides tagged with large fluorescent proteins or reporters such as EGFP, pHluorin, and GCaMP provide a relatively fast readout of peptide release and describe knockout phenotypes related to peptide release in vitro, but this approach is limited to modified peptides, not the endogenous peptides, and is hardly possible to apply in vivo (Burke et al, 1997;de Wit et al, 2009;Ding et al, 2019;Lang et al, 1997;van den Pol, 2012;Xia et al, 2009). Finally cellbased neurotransmitter fluorescent engineered reporters (CNiFERs) have been used to detect neuropeptides; however, the need to implant exogenous cells in specific brain regions limits the utility of this approach (Jones et al, 2018;Lacin et al, 2016;Xiong et al, 2021). Thus, the precise spatiotemporal dynamics and release patterns of endogenous peptides remain poorly understood.…”
Section: Introductionmentioning
confidence: 99%
“…Such changes in SST modulation may contribute to dysregulation of PL cortical neurons and outputs and, ultimately be causal to some disease-relevant behaviors. Importantly, the rapid emergence of new optical biosensors for peptides including SST (Xiong et al ., 2021; Wang et al ., 2022) will allow for new in vivo investigation of neurotransmitter versus peptide dynamics. These emerging technologies will allow for the decoupling of SST peptide signaling versus co-released GABA (and potentially other peptides as well).…”
Section: Discussionmentioning
confidence: 99%